PERHAPS ZYESAMI IS AVIPTADIL, TWEAKED!!!
If you have a new formulation you would be required to do phase 1 dosing and safety studies. Give NRX credit for being bold but if you simply review their own press releases and the CA hard to understand how they took ownership of rlf and cannot see how they are willing to risk the profits they are actually entitled to. What is documented supports relief. The story told in nrx filing is a highly untenable narrative without any documentation. Relief financed this study, had safety studies conducted, had patented formulation which had already been used in humans with documentation. Nrx comes in and says we can tweak this and now we own 20 years of your data. I am not a lawyer but as a layman find this simply impossible to believe legally defensible. We will see. Both stocks will rise with any approvals and clearly Nrx has not responded to legal request for audits. Still believe that Javitts narcissism, actually believing he discovered and developed this drug will be the undoing of his messianic beliefs about himself, and likely will destroy both his and his brothers dream of creating a drug along with the wealth that would come their way. He sold relief on his relationships with fda and just continued upping the ante until relief and likely GEM said enough. Kind of like the guy who puts a fence on your property and then claims it’s my property now. I put up the fence. It works if you wait long enough but always fail if you get legal representation. If Neurorx has good lawyers they will put an end to this nonsense and not create more damages for shareholders of NRXP.
~ just the facts, Y@h00 RLFTF finance conversations
